News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Rapacious Enrichment Of Gilead Sciences, Inc. (GILD)'s CEO


4/3/2014 7:39:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The statutory rape of shareholders by public companies’ managements is awesome and continuous. But, carefully manicured compensation guidelines in proxy statements apparently meet standards that preclude interference by the SEC. Pillage varies directly with the thickness of the proxy document itself. Shareholders rarely vote against “full package” largesse. Institutions look the other way just so long as the stock outperforms.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes


comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES